(Q77744132)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871621%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Endothelin antagonists: evaluation of 2,1,3-benzothiadiazole as a methylendioxyphenyl bioisoster (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871621%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

W W Mederski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871621%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M Osswald

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871621%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

D Dorsch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871621%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

S Anzali

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871621%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M Christadler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871621%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

C J Schmitges

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871621%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

C Wilm

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871621%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871621%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

number of pages

6

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871621%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871621%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871621%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

17-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871621%20AND%20SRC:MED&resulttype=core&format=json

The discovery of sulfonamide endothelin antagonists and the development of the orally active ETA antagonist 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulf onamide.

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2910151-2

7 January 2021

Structure-activity relationships in a series of orally active gamma-hydroxy butenolide endothelin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2910151-2

7 January 2021

2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2910151-2

7 January 2021

1,3-Diarylindan-2-carboxylic acids, potent and selective non-peptide endothelin receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2910151-2

7 January 2021

Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2910151-2

7 January 2021

10.1016/S0960-894X(97)10151-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871621%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference